- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI Summary - About
Selectquote Inc(SLQT)
Advisory History & Simulated Performance *
*as per simulation (see disclosures)- ALL
- 1Y
- 1M
- 1W
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- PASS (Skip)
Advisory Performance History (Simulated)
Upturn Advisory & Investor View for SLQT
11/16/2026: SLQT (1-star) is currently NOT-A-BUY. Pass it for now.
SelectQuote is a technology-enabled direct-to-consumer platform that distributes senior health, life, and auto insurance while operating the SelectRx home-delivery pharmacy service. The company's primary strengths lie in its established brand, extensive senior customer database, and strategic pivot toward recurring healthcare services. Its main growth opportunity centers on cross-selling pharmacy and chronic care management to its senior insurance base. However, key risks include heavy revenue concentration among a few major carriers, strict regulatory oversight, and variable profitability. The stock suits growth-oriented investors willing to tolerate high volatility, with key developments to monitor including SelectRx membership growth and regulatory compliance updates.
How to Read the Upturn Advisory
The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.
Company fundamentals, valuation, risks, and news provide supporting context about the business.
Investor Fit
| Investor style | Fit | Why |
|---|---|---|
| Growth investor | Mixed fit | While SelectRx offers rapid healthcare scaling, overall revenue growth has experienced transitional headwinds. |
| Momentum investor | Weak fit | Stock price trends and sentiment remain subdued, requiring a positive upturn signal before strong momentum interest. |
| Value investor | Mixed fit | Low share price levels offer deep value potential, but ongoing profitability and regulatory risks warrant caution. |
| Dividend investor | Weak fit | The company pays no dividends, focusing entirely on operational reinvestment and debt management. |
| Low-risk investor | Weak fit | High share price volatility and regulatory exposure present substantial risks unsuited for conservative profiles. |
Risk Profile
| Risk factor | Level | Why it matters |
|---|---|---|
| Price volatility | High | The stock experiences sharp swings driven by seasonal earnings and regulatory news. |
| Valuation risk | Medium / high | Market uncertainty creates wide valuation disconnects relative to book value. |
| Competition risk (Digital health broker and carrier competition) | High | Intense competition for senior leads constrains margins and increases customer acquisition costs. |
| Business quality | Medium | While customer retention tools are robust, earnings predictability is impacted by regulatory changes. |
| Dividend income | Low / none | No cash dividends are distributed to shareholders. |
| Execution risk | High | Successfully scaling healthcare services while controlling costs is critical to long-term profitability. |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 79.28M USD | Price to earnings Ratio - | 1Y Target Price 2.1 |
Price to earnings Ratio - | 1Y Target Price 2.1 | ||
Volume (30-day avg) 83.7K shares | Beta 1.95 | 52 Weeks Range 6.00 - 35.20 | Updated Date 11/15/2026 |
52 Weeks Range 6.00 - 35.20 | Updated Date 11/15/2026 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.02 |
Sector & Industry Intelligence
Sector
Financial Services
Constructive- Sentiment
- Strong Bullish
- Momentum
- BUY Breadth Improving
- BUY participation
- 55.0%
- Active BUY / eligible
- 66 / 120
- 30-Day BUY Count Change
- +48
- Market state
- Strong Bullish
More qualifying stocks are receiving or maintaining BUY advisories, indicating improving market participation.
Industry
Insurance Brokers
- BUY participation
- 75.0%
- Active BUY / eligible
- 3 / 4
- 30-Day BUY Count Change
- +2
Eligible universe: 4 stocks.
Sector signal summarizes BUY breadth conditions for the sector. It does not override this stock’s BUY, SELL, or PASS advisory.
Price Behavior

Steep Decline
The stock price has dropped sharply with strong downward pressure.

Extreme Price Shocks
The stock has experienced exceptionally large and disruptive price movements during the period.
Analysis of Past Performance
Type Stock | Historic Profit -26.56% | Avg. Invested days 24 | Today’s Advisory PASS |
Upturn Advisory Rating ![]() | Upturn Advisory Performance | Stock Returns Performance |
Upturn Scorecard
Upturn Star Rating 
Company Fundamentals 
Financial Health Rating 
Growth Momentum Score 
Ownership 
Top 5 Institutional Investors
Unit Economics (Per $1K Revenue) 
Economic Dimensions
Quantitative Style Profile 
Style Classification
Quality Focused
How Company Makes Money
| Business area | What it includes | Retail investor read |
|---|---|---|
| Senior Segment | Commissions and fees from writing Medicare Advantage and Medicare Supplement insurance policies. | Core insurance brokerage commissions that fluctuate with annual Medicare enrollment cycles. |
| Healthcare Services (SelectRx) | Pharmacy dispensing revenue and chronic care management services delivered to home patients. | A recurring healthcare revenue stream focused on servicing patients with complex medical needs. |
| Life Segment | Commissions generated from term life insurance policy placements. | Traditional insurance distribution revenue supporting baseline cash flows. |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Valuation
Trailing PE - | Forward PE 66.67 | Enterprise Value 798.79M | Price to Sales(TTM) 0.05 |
Enterprise Value 798.79M | Price to Sales(TTM) 0.05 | ||
Enterprise Value to Revenue 0.51 | Enterprise Value to EBITDA 5.37 | Shares Outstanding 179.44M | Shares Floating 144.20M |
Shares Outstanding 179.44M | Shares Floating 144.20M | ||
Percent Insiders 10.2 | Percent Institutions 45.55 |
Financial Metrics
🧭 Investment Snapshot
Total Revenue (Scale)
Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.
Net Income (Profit)
Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.
Free Cash Flow (Cash Strength)
Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.
📈 Growth & Strength
Operating Income (Core Profit)
Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.
EBITDA (Cash Earnings)
Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.
Gross Profit (Unit Profitability)
Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.
🛡️ Financial Safety
Cash (Liquidity Buffer)
Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.
Total Debt (Leverage Risk)
Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.
Net Working Capital (Short-Term Health)
Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.
🧱 Balance Sheet Strength
Stockholder Equity (Net Worth)
Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.
Total Assets (Asset Base)
The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.
Income Before Tax (Pre-Tax Earnings)
Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.
⚙️ Cost & Drag Factors
Cost of Revenue (Production Cost)
Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.
Total Operating Expenses (Operating Cost)
Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.
Income Tax Expense (Tax Drag)
Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
All company names, trademarks, logos, and brands are the property of their respective owners and are used for identification and informational purposes only. Use of these names, trademarks, and logos does not imply endorsement by their respective owners.

